SGRY SURGERY PARTNERS INC
2026Q1 · CUSIP 86881A100 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
181
Δ holders QoQ
0
Breadth percentile
Top 62%
Whale holders
98
Δ whales
+2
Inst. holding value
$1.9B
New positions
34
Closed positions
34
Price momentum (1Q)
-10.8%
Put / Call
5/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 11% | -1.7% | -36.2% |
| 2023Q2 | Top 14% | -7.1% | +6.9% |
| 2022Q4 | Top 17% | +4.8% | -7.4% |
| 2022Q1 | Top 19% | -24.1% | -37.5% |
| 2021Q2 | Top 18% | +8.1% | -0.7% |
| 2019Q2 | Top 19% | +99.7% | +216.5% |
Options Sentiment
Put holders
5
QoQ: -2
Call holders
6
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.59
EPS YoY
—
Revenue (TTM)
$3.3B
Revenue YoY
+5.4%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)